|
血栓性血小板减少性紫癜 溶血性尿毒症综合征的研究进展 |
| |
nbsp;K，MAJERUS EM， et al. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13[J].J Biol Chem， 2003，278: 3013631041.
[16] SOEJIMA K, MATSUMOTO M, KOKAME K, et al. ADAMTS13 cysteinerich/spacer domains are functionally essential for von Willebrand factor cleavage[J]. Blood ，2003，102: 32323237.
[17] DONG JF, MOAKE JL, NOLASCO L, et al. ADAMTS13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions[J]. Blood， 2002，100: 40334039.
[18] FURLAN M, LAMMLE B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemoltytic uraemic syndrome:the role of von willebrand fact
orcleaving protease[J]. Best Pract Res Clin Haematol ，2001，14:437454.
[19] MOAKE JL,CHOW TW. Thrombotic thrombocytopenic purpura:understanding a disease no longer rare[J].Am J Med Sci，1998，316:105119.
[20] ESELY SK, GEORGE JN, LAMMLE B, et al. ADAMTS13 activity in thrombotic thrombocytopenic purpurahemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients[J]. Blood，2003，102:6068.
上一页 [1] [2] [3] [4] [5] [6]
上一个医学论文： 人凝血因子 基因多态性与血栓性疾病
下一个医学论文： 炎症与高血压
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文